Ritter Pharmac. Com
NASDAQ:RTTR (5/22/2020, 7:14:30 PM)
After market: 0.46 +0.01 (+2.68%)0.448
+0.01 (+1.82%)
Ritter Pharmaceuticals, Inc. is involved in developing therapeutic products to treat inflammatory, gastrointestinal and metabolic diseases. Its lead product candidate is RP-G28, a novel microbiome modulator, which is under development for the reduction of symptoms associated with lactose intolerance. Ritter Pharmaceuticals, Inc. is headquartered in Los Angeles, California.
Ritter Pharmac. Com
1880 CENTURY PARK EAST SUITE 1000
LOS ANGELES CA 90067
P: 310-203-1000
CEO: Andrew J. Ritter
Ritter Pharmaceuticals (RTTR +7.7%) will finalize its pending merger with Qualigen after the close today. The combined company will do business as Qualigen Therapeutics with shares trading on the Nasd
Will These Penny Stocks Stay Below $2? Penny stocks are always considered…
4 Penny Stocks To Watch After Latest News If one thing’s certain,…
Here you can normally see the latest stock twits on RTTR, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: